CorMedix (CRMD) Net Income (2010 - 2026)
CorMedix (CRMD) posted Net Income of -$11.8 million for Q4 2025, down 110.85% sequentially from $108.6 million in Q3 2025, and down 187.47% YoY from $13.5 million in Q4 2024.
CorMedix (CRMD) Net Income (2010 - 2026) Analysis & Trends
CorMedix has reported Net Income for 16 years, with the latest figure at -$11.8 million in Q4 2025.
- Quarterly Net Income fell 187.47% year-over-year to -$11.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $137.3 million (up 865.52% YoY) and the FY2025 annual result came in at $137.3 million, up 865.52% from the prior year.
- Net Income retreated to -$11.8 million in Q4 2025 per CRMD's latest filing, from $108.6 million in the prior quarter.
- Over five years, Net Income peaked at $108.6 million in Q3 2025 and troughed at -$17.3 million in Q1 2021.
- A 5-year average of $101697.0 and a median of -$8.4 million in 2021 frame the typical range for Net Income.
- The sharpest annual moves came in 2021 and 2025: Net Income tumbled 199.88% in 2021, then soared 4002.28% in 2025.
- Over 5 years, Net Income stood at -$9.7 million in 2021, then gained by 15.08% to -$8.2 million in 2022, then slumped by 79.73% to -$14.8 million in 2023, then jumped by 191.26% to $13.5 million in 2024, then sank by 187.47% to -$11.8 million in 2025.
- According to Business Quant data, Net Income over the past three periods registered -$11.8 million, $108.6 million, and $19.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -13.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn | 25.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.99 Mn |
| Dec 31, 2025 | -11.78 Mn |
| Sep 30, 2025 | 108.56 Mn |
| Jun 30, 2025 | 19.83 Mn |
| Mar 31, 2025 | 20.64 Mn |
| Dec 31, 2024 | 13.46 Mn |
| Sep 30, 2024 | -2.78 Mn |
| Jun 30, 2024 | -14.15 Mn |
| Mar 31, 2024 | -14.47 Mn |
| Dec 31, 2023 | -14.75 Mn |
| Sep 30, 2023 | -9.74 Mn |
| Jun 30, 2023 | -11.27 Mn |
| Mar 31, 2023 | -10.57 Mn |
| Dec 31, 2022 | -8.21 Mn |
| Sep 30, 2022 | -6.85 Mn |
| Jun 30, 2022 | -7.60 Mn |
| Mar 31, 2022 | -8.16 Mn |
| Dec 31, 2021 | -9.67 Mn |
| Sep 30, 2021 | -8.57 Mn |
| Jun 30, 2021 | -4.63 Mn |